Dexcom (DXCM) Retained Earnings (2010 - 2026)

Dexcom (DXCM) has 17 years of Retained Earnings data on file, last reported at $106.2 million in Q1 2026.

• Retained Earnings for Q1 2026 came in at $106.2 million, up 4727.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.2 million (up 4727.27% YoY), and the FY2025 annual result was $2.4 billion, up 52.35% from the prior year.
• Retained Earnings fell to $106.2 million in Q1 2026 per DXCM's latest filing, from $2.4 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $2.4 billion in Q4 2025 and troughed at -$38.0 million in Q2 2024.
• A 5-year average of $618.7 million and a median of $236.0 million in 2022 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2022 and 2024: Retained Earnings surged 95880.0% in 2022, then sank 473.85% in 2024.
• A 5-year view of Retained Earnings shows it stood at $479.9 million in 2022, then soared by 112.84% to $1.0 billion in 2023, then surged by 56.41% to $1.6 billion in 2024, then soared by 52.35% to $2.4 billion in 2025, then sank by 95.64% to $106.2 million in 2026.
• Business Quant data shows DXCM's Retained Earnings at $106.2 million in Q1 2026, $2.4 billion in Q4 2025, and $2.2 billion in Q3 2025.